Searched for
TATVA CHINTAN IPO
Mukul Agrawal’s SME play Monolithisch India rockets 200% in 44 days, 2 more June quarter picks climb up to 67%Ace investor Mukul Agrawal’s recent picks, Monolithisch India, Yatharth Hospital, and Tatva Chintan, have delivered impressive returns in F...- Tatva Chintan Pharma shares tumble 9% post Dec quarter earningsThe Ebitda declined 6 per cent to Rs 23 crore compared with Rs 25 crore posted last year. The company’s margin contracted to 22 per cent in...
- Going by history, Paras Defence set to deliver big listing pop FridaySalasar Techno Engineering's 2017 IPO saw a massive 273 times bids, a record for highest subscription that was maintained for four years un...
- IPO Street’s paved with gold? Retail investors can’t stop buyingThe average listing day gains of five IPOs in July was 76%. Tatva Chintan Pharma listed at a premium of 113%, GR Infraprojects rallied 109%...
- Rolex Rings initial offer subscribed 130 timesThe `731-crore initial public offering of Rolex Rings, an automotive component company, was subscribed 130 times on Friday— the last day of...
- Tatva Chintan surges over 100% on day 1Tatva Chintan's first-day pop is among the strongest listings that the market has seen of late. Recently, food delivery platform Zomato lis...
- Tatva Chintan lists at 95% premium over issue priceThe strong listing was in line with the recent trend, wherein market debutants have delivered 50-100 per cent returns at listing.
- Will Tatva Chintan do a GR Infra on listing? Grey market says soThe grey market premium for the stock has surged to Rs 1,140-1,150 per share in the unofficial market, which can translate into 105-110 per...
- Grey market premium hits crazy levels; time to turn cautious?Dealers in the market in unlisted shares said grey market premium for Tatva Chintan Pharma Chem has jumped to Rs 1,140-1,150 over its price...
- Tatva Chintan IPO allotment: Check GMP and application statusThe basis of allotment for shares of Tatva Chintan is likely to be finalised by Monday, July 26. The shares of the company are expected to ...
- Tatva Chintan Pharma’s IPO subscribed 180 timesThis is the second-best IPO so far this year in terms of investor demand. Earlier in March, the ₹596-crore IPO of MTAR Technologies was sub...
- Tatva Chintan IPO subscribed 180.4 times on Day 3; GMP spikes to 70%Tatva Chintan Pharma Chem has already received bids worth Rs 149.99 crore from 22 anchor investors at the upper price band of Rs 1,083 per ...
- Tatva Chintan Pharma Chem IPO subscribed 15 times on Day 2Tatva Chintan Pharma Chem has already received bids worth Rs 149.99 crore from 22 anchor investors at the upper price band of Rs 1,083 per ...
- Tatva Chintan Pharma Chem IPO subscribed 4.5 times on Day 1Most analysts have advised investors to subscribe to the Rs 500 crore initial public offering (IPO). The price band of the issue has been f...
- Tatva Chintan to use IPO proceeds for growth, not to repay debt: Chintan Shah“We would continue to spend 2% to 3% of revenue on R&D and that would translate into a strong top line growth.”
- Tatva Chintan’s valuation, high margins may attract investorsLong-term investors may subscribe to the IPO given the reasonable valuation, higher return ratios supported by tax holidays and rising prop...
- Tatva Chintan Pharma Chem's Rs 500 cr IPO to open on July 16The offer size is Rs 500 crore, of which the company will issue fresh equity shares worth Rs 225 crore and offer for sale by promoters and ...
- Zomato IPO likely to sail through despite concernsExperts say profitability concerns, offer size may keep a lid on subscription numbers
- Chemplast Sanmar, Tatva Chintan Pharma Chem get Sebi nod for IPOsChemplast Sanmar and Tatva Chintan Pharma Chem obtained Sebi's observations on July 2 and June 30 respectively, an update with Sebi showed ...
- Tatva Chintan Pharma Chem files papers for Rs 450 cr IPOThe initial public offer (IPO) comprises fresh issuance of equity shares worth Rs 225 crore and an offer of sale to the tune of Rs 225 cror...
Load More
